MicroRNA-133a-5p inhibiting metastatic capacity of renal clear cell carcinoma through regulating MON2

P Li1, Q Wu, X-R Yang

  • 1Department of Urology, The First Affiliated Hospital of Nanchang University, Nanchang, China. suntingdr@163.com.

Abstract

Insights

Reduced microRNA-133a-5p expression in clear cell renal cell carcinoma (ccRCC) predicts poor prognosis. This microRNA suppresses ccRCC cell proliferation and metastasis by targeting MON2.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Clear cell renal cell carcinoma (ccRCC) is a significant health concern.
  • Understanding the molecular mechanisms underlying ccRCC progression is crucial for developing effective therapies.
  • MicroRNAs play vital roles in cancer development and progression.

Purpose of the Study:

  • To investigate the correlation between microRNA-133a-5p expression and clinicopathological parameters in ccRCC patients.
  • To explore the functional role of microRNA-133a-5p in ccRCC cell biological behavior.
  • To elucidate the underlying molecular mechanism of microRNA-133a-5p in ccRCC.

Main Methods:

  • Quantitative real-time polymerase chain reaction (qRT-PCR) was used to examine microRNA-133a-5p and MON2 expression in ccRCC tissues and cell lines.
  • Cell Counting Kit-8 (CCK-8) and transwell assays were performed to evaluate the effects of microRNA-133a-5p on ccRCC cell proliferation and invasion.
  • Bioinformatics analysis and Luciferase assays were employed to identify and validate the downstream target of microRNA-133a-5p.

Main Results:

  • MicroRNA-133a-5p expression was significantly reduced in ccRCC tissues and cell lines, correlating with poor prognosis.
  • Overexpression of microRNA-133a-5p inhibited the proliferation and migration of ccRCC cells.
  • MON2 was identified as a direct target of microRNA-133a-5p, and its expression was inversely correlated with microRNA-133a-5p in ccRCC.

Conclusions:

  • Reduced microRNA-133a-5p expression serves as a potential biomarker for predicting poor prognosis in ccRCC patients.
  • MicroRNA-133a-5p suppresses ccRCC cell proliferation and metastasis.
  • The inhibitory effects of microRNA-133a-5p on ccRCC progression are mediated through its regulation of MON2.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.6K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.7K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.3K